A CLINICAL STUDY ON EFFECT OF AMALAKI (INDIAN GOOSEBERRY) AS FOOD SUPPLEMENT IN DYSLIPIDEMIA

Abstract

Dyslipidemia is a condition which is an iceberg. Amalaki (Embelica officinalis Garten) is a fruit listed under wholesome and daily consumables in Ayurveda classics with its components said to improve lipid metabolism and prevent oxidative stress. This directed towards Amalaki to be used as food supplement in dyslipidemia. An open randomized study involving diagnosed cases of dyslipidemia with or without symptoms. The study involved subjects with age group of 20 to 70 years irrespective of the gender. The diagnostic criteria were as mentioned by American Heart Association. Study involved two groups. Amalaki group (study group) was administered with 12 grams of Amalaki choorna to be consumed with major food of the day. The Diet group (control group) was advised minimal dietary manipulations. Study duration was 2 months and biochemical analysis of lipid was done before treatment and after 2 months. Data was analysed with suitable statistical methods. Out of 116 subjects, 102 subjects completed the study. Majority (69%) had Kapha-Vata Prakriti. Majority had overweight and with waist hip ratio increased. When tested between the group, Amalaki group showed a better results in TC (p value 0.014), HDL-C (p value 0.001) and triglycerides (p value < 0.002). The result of LDL between group was found to be not significant with p value 0.898 ( > 0.05). The study concludes that administration of Amalaki Choorna (powder of Emblica officinalis Garten) is a possible food supplement of choice that manages dyslipidemia significantly without causing any adverse effects.